Covered recipient · General Payments record

GREGORY A VIDAL

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI: 1730403072
CMS profile: 811252
Location: GERMANTOWN, TN

General Payments · PY2018–2024

$334,651.16

Reported across 444 records
CMS publication 2026-01-23

Latest program year · PY2024

$51,297.73

72 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Consulting Fee	$46,233.58	18
Food and Beverage	$2,366.85	44
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$1,800.00	1
Long term medical supply or device loan	$897.30	9

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
Gilead Sciences, Inc.	$35,576.93	28
Acerta Pharma LLC	$5,083.04	9
PFIZER INC.	$1,800.00	1
Eli Lilly and Company	$1,676.80	2
Genentech, Inc.	$1,618.02	2
AstraZeneca UK Limited	$1,605.00	1
Daiichi Sankyo Inc.	$1,536.45	3
NOVARTIS PHARMACEUTICALS CORPORATION	$939.62	10
Lilly USA, LLC	$864.53	4
TerSera Therapeutics LLC	$197.30	4
Tempus AI, Inc	$196.93	4
BioNTech SE	$81.46	1
Celgene Corporation	$75.00	1
Merck Sharp & Dohme Corporation	$28.10	1
ABBVIE INC.	$18.55	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$54,383.60	106
PY2019	$88,613.24	90
PY2020	$31,416.39	37
PY2021	$33,974.68	34
PY2022	$32,625.28	53
PY2023	$42,340.24	52
PY2024	$51,297.73	72

Payment records · PY2024 (72)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
ABBVIE INC.	$18.55	01/23/2024	Food and Beverage	Undisputed	01/23/2026	1106283282	CMS
AstraZeneca Pharmaceuticals LP	$535.00	01/01/2024	Consulting Fee	Undisputed	01/23/2026	1104461304	CMS
AstraZeneca Pharmaceuticals LP	$53.34	04/18/2024	Food and Beverage	Undisputed	01/23/2026	1105219867	CMS
AstraZeneca Pharmaceuticals LP	$135.00	06/02/2024	Food and Beverage	Undisputed	01/23/2026	1105858382	CMS
AstraZeneca Pharmaceuticals LP	$1,605.00	06/03/2024	Consulting Fee	Undisputed	01/23/2026	1104315426	CMS
AstraZeneca Pharmaceuticals LP	$535.00	10/01/2024	Consulting Fee	Undisputed	01/23/2026	1105750661	CMS
AstraZeneca Pharmaceuticals LP	$1,600.00	11/19/2024	Consulting Fee	Undisputed	01/23/2026	1104319846	CMS
AstraZeneca Pharmaceuticals LP	$11.92	12/11/2024	Food and Beverage	Undisputed	01/23/2026	1104450822	CMS
AstraZeneca Pharmaceuticals LP	$72.78	12/12/2024	Food and Beverage	Undisputed	01/23/2026	1104719375	CMS
AstraZeneca Pharmaceuticals LP	$535.00	12/20/2024	Consulting Fee	Undisputed	01/23/2026	1104198541	CMS
AstraZeneca UK Limited	$1,605.00	02/08/2024	Consulting Fee	Undisputed	01/23/2026	1093961730	CMS
BioNTech SE	$81.46	10/12/2024	Food and Beverage	Undisputed	01/23/2026	1150660436	CMS
Celgene Corporation	$75.00	05/09/2024	Food and Beverage	Undisputed	01/23/2026	1101112576	CMS
Daiichi Sankyo Inc.	$52.69	06/03/2024	Food and Beverage	Undisputed	01/23/2026	1089494966	CMS
Daiichi Sankyo Inc.	$146.26	06/03/2024	Food and Beverage	Undisputed	01/23/2026	1089494968	CMS
Daiichi Sankyo Inc.	$1,337.50	10/30/2024	Consulting Fee	Undisputed	01/23/2026	1089494944	CMS
Eli Lilly and Company	$1,600.00	11/27/2024	Consulting Fee	Undisputed	01/23/2026	1134990130	CMS
Eli Lilly and Company	$76.80	12/11/2024	Food and Beverage	Undisputed	01/23/2026	1134990128	CMS
Genentech, Inc.	$1,562.50	09/16/2024	Consulting Fee	Undisputed	01/23/2026	1133016780	CMS
Genentech, Inc.	$55.52	09/16/2024	Food and Beverage	Undisputed	01/23/2026	1133016785	CMS
Gilead Sciences, Inc.	$114.00	02/04/2024	Food and Beverage	Undisputed	01/23/2026	1133831441	CMS
Gilead Sciences, Inc.	$2,870.00	02/06/2024	Consulting Fee	Undisputed	01/23/2026	1133600077	CMS
Gilead Sciences, Inc.	$24.53	02/21/2024	Food and Beverage	Undisputed	01/23/2026	1133831443	CMS
Gilead Sciences, Inc.	$3,820.00	03/06/2024	Consulting Fee	Undisputed	01/23/2026	1133600079	CMS
Gilead Sciences, Inc.	$25.64	03/27/2024	Food and Beverage	Undisputed	01/23/2026	1133831445	CMS
Gilead Sciences, Inc.	$29.64	04/24/2024	Food and Beverage	Undisputed	01/23/2026	1133831447	CMS
Gilead Sciences, Inc.	$960.00	06/01/2024	Consulting Fee	Undisputed	01/23/2026	1133600081	CMS
Gilead Sciences, Inc.	$51.74	06/01/2024	Food and Beverage	Undisputed	01/23/2026	1133831449	CMS
Gilead Sciences, Inc.	$80.77	06/03/2024	Food and Beverage	Undisputed	01/23/2026	1133831451	CMS
Gilead Sciences, Inc.	$27.83	08/22/2024	Food and Beverage	Undisputed	01/23/2026	1133831453	CMS
Gilead Sciences, Inc.	$13.54	08/23/2024	Food and Beverage	Undisputed	01/23/2026	1133831455	CMS
Gilead Sciences, Inc.	$16.32	08/23/2024	Food and Beverage	Undisputed	01/23/2026	1133831457	CMS
Gilead Sciences, Inc.	$21.04	09/03/2024	Food and Beverage	Undisputed	01/23/2026	1133831459	CMS
Gilead Sciences, Inc.	$8,878.58	09/10/2024	Consulting Fee	Undisputed	01/23/2026	1133600083	CMS
Gilead Sciences, Inc.	$97.17	09/14/2024	Food and Beverage	Undisputed	01/23/2026	1133831461	CMS
Gilead Sciences, Inc.	$13.10	09/15/2024	Food and Beverage	Undisputed	01/23/2026	1133831463	CMS
Gilead Sciences, Inc.	$35.22	09/15/2024	Food and Beverage	Undisputed	01/23/2026	1133831465	CMS
Gilead Sciences, Inc.	$45.77	09/15/2024	Food and Beverage	Undisputed	01/23/2026	1133831467	CMS
Gilead Sciences, Inc.	$56.27	09/15/2024	Food and Beverage	Undisputed	01/23/2026	1133831469	CMS
Gilead Sciences, Inc.	$15.85	09/16/2024	Food and Beverage	Undisputed	01/23/2026	1133831471	CMS
Gilead Sciences, Inc.	$480.00	10/15/2024	Consulting Fee	Undisputed	01/23/2026	1133600085	CMS
Gilead Sciences, Inc.	$12,000.00	11/19/2024	Consulting Fee	Undisputed	01/23/2026	1133600087	CMS
Gilead Sciences, Inc.	$17.45	12/11/2024	Food and Beverage	Undisputed	01/23/2026	1133831473	CMS
Gilead Sciences, Inc.	$108.95	12/11/2024	Food and Beverage	Undisputed	01/23/2026	1133831475	CMS
Gilead Sciences, Inc.	$113.52	12/12/2024	Food and Beverage	Undisputed	01/23/2026	1133831477	CMS
Gilead Sciences, Inc.	$150.00	12/12/2024	Food and Beverage	Undisputed	01/23/2026	1133831479	CMS
Gilead Sciences, Inc.	$1,440.00	12/17/2024	Consulting Fee	Undisputed	01/23/2026	1133600089	CMS
Gilead Sciences, Inc.	$4,070.00	12/18/2024	Consulting Fee	Undisputed	01/23/2026	1133600091	CMS
Lilly USA, LLC	$800.00	02/09/2024	Consulting Fee	Undisputed	01/23/2026	1134990132	CMS
Lilly USA, LLC	$22.96	05/01/2024	Food and Beverage	Undisputed	01/23/2026	1135007121	CMS
Lilly USA, LLC	$30.70	08/13/2024	Food and Beverage	Undisputed	01/23/2026	1134991798	CMS
Lilly USA, LLC	$10.87	08/13/2024	Food and Beverage	Undisputed	01/23/2026	1135007123	CMS
Merck Sharp & Dohme LLC	$28.10	08/13/2024	Food and Beverage	Undisputed	01/23/2026	1141795685	CMS
Novartis Pharmaceuticals Corporation	$99.70	04/18/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087422658	CMS
Novartis Pharmaceuticals Corporation	$99.70	05/16/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087422662	CMS
Novartis Pharmaceuticals Corporation	$99.70	06/13/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087422666	CMS
Novartis Pharmaceuticals Corporation	$99.70	07/15/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087422670	CMS
Novartis Pharmaceuticals Corporation	$99.70	08/23/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087422644	CMS
Novartis Pharmaceuticals Corporation	$99.70	09/27/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087422650	CMS
Novartis Pharmaceuticals Corporation	$99.70	10/17/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087422678	CMS
Novartis Pharmaceuticals Corporation	$99.70	11/14/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087422674	CMS
Novartis Pharmaceuticals Corporation	$99.70	12/10/2024	Long term medical supply or device loan	Undisputed	01/23/2026	1087422682	CMS
Novartis Pharmaceuticals Corporation	$42.32	12/10/2024	Food and Beverage	Undisputed	01/23/2026	1087422686	CMS
PFIZER INC.	$1,800.00	07/31/2024	Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	Undisputed	01/23/2026	1131359863	CMS
Tempus AI, Inc	$96.75	08/19/2024	Food and Beverage	Undisputed	01/23/2026	1150176563	CMS
Tempus AI, Inc	$62.03	09/18/2024	Food and Beverage	Undisputed	01/23/2026	1150176565	CMS
Tempus AI, Inc	$25.75	11/21/2024	Food and Beverage	Undisputed	01/23/2026	1150176567	CMS
Tempus AI, Inc	$12.40	12/06/2024	Food and Beverage	Undisputed	01/23/2026	1150176569	CMS
TerSera Therapeutics LLC	$8.53	08/21/2024	Food and Beverage	Undisputed	01/23/2026	1144715283	CMS
TerSera Therapeutics LLC	$32.05	09/05/2024	Food and Beverage	Undisputed	01/23/2026	1144715285	CMS
TerSera Therapeutics LLC	$120.42	12/06/2024	Food and Beverage	Undisputed	01/23/2026	1144715287	CMS
TerSera Therapeutics LLC	$36.30	12/08/2024	Food and Beverage	Undisputed	01/23/2026	1144715289	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.